Vaccine Production
-
{
- All
- News
- Videos
-
India Gets New Vaccine Tools To Fight Tuberculosis In Adolescents: Not 'A Magic Bullet' But A Good Breakthrough
While the vaccines are products of private sector innovation, their evaluation has been firmly anchored in public science, with a large, independent Phase III clinical trial led, funded and sponsored by the Indian Council of Medical Research (ICMR).
-
Newcastle Disease Spreads Across Europe: Here's What You Should Know About The Viral Infection
Newcastle disease is highly contagious and can cause respiratory trouble, drop in egg production, and even 100 percent mortality in severe outbreaks.
-
No Shortage Of Anti-Rabies Vaccine, Rabies Immunoglobulin In India: Union Health Minister J P Nadda
Union Health Minister J P Nadda on Tuesday asserted that there is no shortage of Rabies Immunoglobulin (RIG) and Anti-Rabies Vaccine (ARV) in the country as supply far exceeds domestic demand.
-
Rajasthan Launches Massive 2-Crore Cattle Vaccination Drive to Stamp Out Foot Mouth Disease
Rajasthan launches FMD drive to vaccinate 2.32 crore cattle, aiming for disease-free state by 2030.
-
Your Age May Influence Antibody Production In Response To A Virus: Study
Age strongly influences antibody production against viruses, researchers find. A Nature Immunology study shows age, sex, and genetics shape immune responses, with implications for tailored treatments.
-
Thyroid Health A National Priority, Awareness And Research Partnerships Needed, Says Minister
Union Minister Dr. Jitendra Singh emphasised that thyroid disorders are a major national health challenge impacting productivity and demographics
-
South Africa Rolls Out First Locally Produced Foot-And-Mouth Vaccine In 20 Years
South Africa has released its first locally produced vaccine for foot-and-mouth disease (FMD) in nearly two decades, the country's Department of Agriculture said.
-
World Immunization Day 2025: Expanding Adult Vaccines To Guard India's Health
While childhood programs have progressed, adult vaccine coverage remains low in India. From influenza and pneumococcal to HPV and zoster, adult-vaccines can protect health, productivity and public welfare.
-
Key Points Of WHO Pandemic Agreement
The WHO Pandemic Agreement, an accord designed to address the mistakes made in handling COVID-19, is being submitted for adoption Tuesday at the World Health Assembly.
-
"Not Humanly Possible To...": Adar Poonawalla On Work Hours vs Productivity
Amid the nationwide debate on work-life balance after problematic remarks by some industry leaders, Adar Poonawalla, CEO of vaccine manufacturer Serum Institute, has said it is not humanly possible to be productive beyond a certain number of hours
-
"Critical Shortage" Of Cholera Vaccine, Says WHO, Calls for Production Boost
The head of the World Health Organization on Thursday called for increased production of cholera vaccines, highlighting what he called a "critical shortage" around the globe.
-
"We Disclosed All Rare Side-Effects": Covid Vaccine Maker Amid Safety Row
The Serum Institute - which manufactured the Covishield COVID-19 vaccine developed by British pharma giant AstraZeneca - stressed on Wednesday that all its product packaging had "disclosed all rare to very rare side-effects", including TTS.
-
Will Bring Out List of Scams In Mumbai Civic Body During MVA Term: D Fadnavis
Devendra Fadnavis on Wednesday said when Prime Minister Narendra Modi was facilitating vaccine production in the country during the pandemic, the then-MVA government in the state was indulging in alleged scams.
-
Sharad Pawar Demands Bharat Ratna For Serum Institute Founder Cyrus Poonawalla
Praising the work done by the founder of the Serum Institute of India (SII), in the field of vaccine production, founder of Nationalist Congress Party (NCP) Sharad Pawar demanded that Cyrus Poonawalla be honoured with the Bharat Ratna award.
-
Serum Institute Restarts Production Of Covishield Vaccine After Cases Rise
Serum Institute of India CEO Adar Poonawalla on Wednesday said the company has restarted manufacturing of COVID-19 vaccine Covishield amid rising numbers of cases of the virus infection.
-
India Gets New Vaccine Tools To Fight Tuberculosis In Adolescents: Not 'A Magic Bullet' But A Good Breakthrough
While the vaccines are products of private sector innovation, their evaluation has been firmly anchored in public science, with a large, independent Phase III clinical trial led, funded and sponsored by the Indian Council of Medical Research (ICMR).
-
Newcastle Disease Spreads Across Europe: Here's What You Should Know About The Viral Infection
Newcastle disease is highly contagious and can cause respiratory trouble, drop in egg production, and even 100 percent mortality in severe outbreaks.
-
No Shortage Of Anti-Rabies Vaccine, Rabies Immunoglobulin In India: Union Health Minister J P Nadda
Union Health Minister J P Nadda on Tuesday asserted that there is no shortage of Rabies Immunoglobulin (RIG) and Anti-Rabies Vaccine (ARV) in the country as supply far exceeds domestic demand.
-
Rajasthan Launches Massive 2-Crore Cattle Vaccination Drive to Stamp Out Foot Mouth Disease
Rajasthan launches FMD drive to vaccinate 2.32 crore cattle, aiming for disease-free state by 2030.
-
Your Age May Influence Antibody Production In Response To A Virus: Study
Age strongly influences antibody production against viruses, researchers find. A Nature Immunology study shows age, sex, and genetics shape immune responses, with implications for tailored treatments.
-
Thyroid Health A National Priority, Awareness And Research Partnerships Needed, Says Minister
Union Minister Dr. Jitendra Singh emphasised that thyroid disorders are a major national health challenge impacting productivity and demographics
-
South Africa Rolls Out First Locally Produced Foot-And-Mouth Vaccine In 20 Years
South Africa has released its first locally produced vaccine for foot-and-mouth disease (FMD) in nearly two decades, the country's Department of Agriculture said.
-
World Immunization Day 2025: Expanding Adult Vaccines To Guard India's Health
While childhood programs have progressed, adult vaccine coverage remains low in India. From influenza and pneumococcal to HPV and zoster, adult-vaccines can protect health, productivity and public welfare.
-
Key Points Of WHO Pandemic Agreement
The WHO Pandemic Agreement, an accord designed to address the mistakes made in handling COVID-19, is being submitted for adoption Tuesday at the World Health Assembly.
-
"Not Humanly Possible To...": Adar Poonawalla On Work Hours vs Productivity
Amid the nationwide debate on work-life balance after problematic remarks by some industry leaders, Adar Poonawalla, CEO of vaccine manufacturer Serum Institute, has said it is not humanly possible to be productive beyond a certain number of hours
-
"Critical Shortage" Of Cholera Vaccine, Says WHO, Calls for Production Boost
The head of the World Health Organization on Thursday called for increased production of cholera vaccines, highlighting what he called a "critical shortage" around the globe.
-
"We Disclosed All Rare Side-Effects": Covid Vaccine Maker Amid Safety Row
The Serum Institute - which manufactured the Covishield COVID-19 vaccine developed by British pharma giant AstraZeneca - stressed on Wednesday that all its product packaging had "disclosed all rare to very rare side-effects", including TTS.
-
Will Bring Out List of Scams In Mumbai Civic Body During MVA Term: D Fadnavis
Devendra Fadnavis on Wednesday said when Prime Minister Narendra Modi was facilitating vaccine production in the country during the pandemic, the then-MVA government in the state was indulging in alleged scams.
-
Sharad Pawar Demands Bharat Ratna For Serum Institute Founder Cyrus Poonawalla
Praising the work done by the founder of the Serum Institute of India (SII), in the field of vaccine production, founder of Nationalist Congress Party (NCP) Sharad Pawar demanded that Cyrus Poonawalla be honoured with the Bharat Ratna award.
-
Serum Institute Restarts Production Of Covishield Vaccine After Cases Rise
Serum Institute of India CEO Adar Poonawalla on Wednesday said the company has restarted manufacturing of COVID-19 vaccine Covishield amid rising numbers of cases of the virus infection.
